Dr. Donoviel oversees the diverse portfolio of science and technology research and development projects at NSBRI that address the challenges faced by humans in space. She leads the NSBRI Industry Forum and the SMARTCAP seed award program for commercialization of biomedical technologies co-developed for both space and Earth-based markets. Dr. Donoviel is Director of the Laboratory for Biomedical Innovations where she evaluates emerging medical products that have the potential to transform medical care in space and on Earth.
Dr. Donoviel is also an Assistant Professor in the Department of Pharmacology and Center for Space Medicine at Baylor College of Medicine, lecturing and mentoring medical students in space biomedical research.
Before joining NSBRI, Dr. Donoviel worked in Pharmaceutical Discovery for 8 years at Lexicon Pharmaceuticals, a biotechnology company based in The Woodlands, Texas. She managed a metabolism research group that identified and validated targets for drug discovery by using in-vivo functional genomics technology, and developed small molecule compounds, antibody, and protein therapeutics against these validated targets.